Nathan Nolop

Nathan Nolop is a Vice President at General Atlantic, where expertise lies in investment within the life sciences sector for a $75 billion global growth equity fund. Previously, Nathan served as a Senior Associate at Veritas Capital, managing due diligence and investments across healthcare technology and government services for a $6.5 billion fund. Prior experience includes roles as an Associate at Hellman & Friedman, focusing on due diligence in financial services and healthcare, and as an Investment Banking Analyst at Morgan Stanley. Nathan holds an MBA from Stanford University Graduate School of Business and a BA in Economics with Distinction, along with a Minor in Classics from Stanford University.